<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To delineate the phenotypic and molecular spectrum of patients with a syndromic variant of severe <z:hpo ids='HP_0005549'>congenital neutropenia</z:hpo> <z:chebi fb="0" ids="29425">(SCN)</z:chebi> due to mutations in the gene encoding <z:chebi fb="105" ids="17234">glucose</z:chebi>-6-phosphatase catalytic subunit 3 (G6PC3) </plain></SENT>
<SENT sid="1" pm="."><plain>STUDY DESIGN: Patients with syndromic <z:chebi fb="0" ids="18022">SCN</z:chebi> were characterized for associated malformations and referred to us for G6PC3 mutational analysis </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: In a cohort of 31 patients with syndromic <z:chebi fb="0" ids="18022">SCN</z:chebi>, we identified 16 patients with G6PC3 deficiency including 11 patients with novel biallelic mutations </plain></SENT>
<SENT sid="3" pm="."><plain>We show that nonhematologic features of G6PC3 deficiency are good predictive indicators for mutations in G6PC3 </plain></SENT>
<SENT sid="4" pm="."><plain>Additionally, we demonstrate genetic variability in this disease and define novel features such as <z:hpo ids='HP_0000824'>growth hormone deficiency</z:hpo>, genital malformations, disrupted bone remodeling, and <z:hpo ids='HP_0001574'>abnormalities of the integument</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>G6PC3 mutations may be associated with <z:hpo ids='HP_0000126'>hydronephrosis</z:hpo> or <z:hpo ids='HP_0001999'>facial dysmorphism</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The risk of transition to <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>/<z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> may be lower than in other genetically defined <z:chebi fb="0" ids="18022">SCN</z:chebi> subgroups </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: The phenotypic and molecular spectrum in G6PC3 deficiency is wider than previously appreciated </plain></SENT>
<SENT sid="8" pm="."><plain>The risk of transition to <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> or <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> may be lower in G6PC3 deficiency compared with other subgroups of <z:chebi fb="0" ids="18022">SCN </z:chebi></plain></SENT>
</text></document>